Roger Kang is a Managing Partner at Medivate Partners, whose known portfolio counts 8 companies.
Is Roger Kang a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- Healthcare
Contacts
Affiliated funds' portfolios
Managing Partner at Medivate Partners, whose known portfolio counts 8 companies
- WindMIL Therapeutics
- Cipherome
- Cognate BioServices
- Artiva Biotherapeutics
- Genopis
- SillaJen
- SoVarGen
- WCCT Global
Investor Profile
The listing covers sector Healthcare, and focus areas Biotech, CDMO, Cell Therapy and Drug Discovery. Startups operating in these areas may find Roger Kang relevant.
Medivate Partners appears in Seed, Series A and Series B rounds across its known deals.
The firm portfolio and the focus above give founders context on whether Roger Kang matches their raise.
Frequently asked questions
Who is Roger Kang?
Roger Kang is a private equity investor and venture capital investor based in South Korea, listed as Managing Partner at Medivate Partners. The known portfolio of that firm counts 8 companies. That portfolio belongs to the firm, not to Roger Kang personally.
What does Roger Kang invest in?
Listed sectors include Healthcare; listed focus areas include Biotech, CDMO, Cell Therapy and Drug Discovery. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Roger Kang invest at?
Medivate Partners appears in Seed, Series A and Series B rounds across its known deals, and Roger Kang is listed there as Managing Partner. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is Roger Kang listed at?
Roger Kang is listed as Managing Partner at Medivate Partners, whose known portfolio counts 8 companies.
How do I contact Roger Kang?
An email address, a phone number and a LinkedIn page are on file for Roger Kang. The address stays masked on this page and is readable inside RaiseHunt after you create an account.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal